Gilead Sciences Rg
GILD
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
07/01/2025 - 02:00:00
Bid
07/01/2025 - 12:30:56
Bid
Volume
Ask
07/01/2025 - 12:30:56
Ask
Volume
110.87
+0.20 ( +0.18% )
110.72
100
111.44
100
More information
Analysis by TheScreener
27.06.2025
Evaluation Slightly positive  
Interest Weak  
Sensibility Low  
Analysis date: 27.06.2025
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 17.06.2025.
Interest
  Weak
Two stars since 24.06.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 20.06.2025 at a price of 108.50.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Positive
 
The forty day technical trend is positive since 20.05.2025.
4wk Rel Perf
  -2.44%
 
The four-week dividend-adjusted underperformance versus SP500 is 2.44%.
Sensibility
  Low
Low, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.56%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.18%.
Mkt Cap in $bn
  137.67
With a market capitalization >$8bn, GILEAD SCIENCES is considered a large-cap stock.
G/PE Ratio
  1.68
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  10.37
The estimated PE is for the year 2028.
LT Growth
  14.47%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
  2.90%
The twelve month estimated dividend yield represents 30.04% of earnings forecasts.
Beta
  29
For 1% of index variation, the stock varies on average by 0.29%.
Correlation
  0.22
Stock movements are strongly independent of index variations.
Value at Risk
  9.67
The value at risk is estimated at USD 9.67. The risk is therefore 8.74%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002